Stay updated on Pembrolizumab Plus Entinostat in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces the previous v3.4.2 on the page.
    Difference
    0.1%
    Check dated 2026-03-11T23:53:21.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    No additions or deletions were detected; the page content appears unchanged.
    Difference
    0.1%
    Check dated 2026-03-04T23:43:52.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Melanoma and related topics (MedlinePlus Genetics) were added, and the site revision was updated to v3.4.2 while the prior downtime notice (v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-11T12:34:40.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and operations. Updated the page to Revision: v3.4.1 and removed Revision: v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T07:39:55.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Glossary display was added and QC-related metadata was updated (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). In addition, content related to Melanoma and some related topics appears removed or renamed, indicating minor UI/content adjustments.
    Difference
    0.4%
    Check dated 2026-01-28T05:39:29.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Added Melanoma and related topics: MedlinePlus Genetics to the related topics section. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-21T04:19:07.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus Entinostat in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page.